The role of mobile health technologies in allergy care: An EAACI position paper
The role of mobile health technologies in allergy care: An EAACI position paper
复制标题
DOI：
10.1111/all.13953
复制
发表时间：
2019-09-16
期刊：
影响因子：
12.4
通讯作者：
Agache, Ioana
中科院分区：
文献类型：
--
作者：
Matricardi, Paolo Maria;Dramburg, Stephanie;Agache, Ioana
移动健康(MHealth)使用智能手机和平板电脑等移动通信设备，从第一次诊断到优化治疗，支持和改进与健康相关的服务、数据流和信息流、患者自我管理、监测和疾病管理。欧洲过敏和临床免疫学学会成立了一个特别工作组，以评估mHealth在过敏学中的技术现状和未来潜力。工作组批准了世卫组织的“Be he@lthy，be Mobile”倡议，并就过敏性疾病移动解决方案的质量、可用性、效率、优势、局限性和风险进行了辩论。在这份立场文件中总结了这些结果，并分析了与《一般数据保护条例》和欧洲共同体医疗指令有关的监管背景。该工作组评估了mHealth产品的设计、用户参与度、内容、引发行为改变的潜力、可信度/问责制和隐私政策。讨论了医疗保健专业人员和过敏患者的观点，强调有必要进行彻底调查，以有效设计mHealth技术，作为提高护理质量的辅助工具。在精准医学的背景下，这些可以促进从临床医生为中心的护理转变为以患者为中心的护理。然后研究mHealth在过敏学特定领域的当前和未来潜力，包括过敏性鼻炎、空气生物学、过敏原免疫治疗、哮喘、皮肤病、食物过敏、过敏反应、昆虫毒液和药物过敏。概述了移动技术和相关大数据集的影响。列出了EAACI中未来移动健康倡议的事实和建议。
Mobile health (mHealth) uses mobile communication devices such as smartphones and tablet computers to support and improve health-related services, data and information flow, patient self-management, surveillance, and disease management from the moment of first diagnosis to an optimized treatment. The European Academy of Allergy and Clinical Immunology created a task force to assess the state of the art and future potential of mHealth in allergology. The task force endorsed the "Be He@lthy, Be Mobile" WHO initiative and debated the quality, usability, efficiency, advantages, limitations, and risks of mobile solutions for allergic diseases. The results are summarized in this position paper, analyzing also the regulatory background with regard to the "General Data Protection Regulation" and Medical Directives of the European Community. The task force assessed the design, user engagement, content, potential of inducing behavioral change, credibility/accountability, and privacy policies of mHealth products. The perspectives of healthcare professionals and allergic patients are discussed, underlining the need of thorough investigation for an effective design of mHealth technologies as auxiliary tools to improve quality of care. Within the context of precision medicine, these could facilitate the change in perspective from clinician- to patient-centered care. The current and future potential of mHealth is then examined for specific areas of allergology, including allergic rhinitis, aerobiology, allergen immunotherapy, asthma, dermatological diseases, food allergies, anaphylaxis, insect venom, and drug allergy. The impact of mobile technologies and associated big data sets are outlined. Facts and recommendations for future mHealth initiatives within EAACI are listed.